상세 보기
A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).
- Park, Sehhoon;
- Lee, Yun-Gyoo;
- Park, Ji Hyun;
- Lee, Gyeong-Won;
- Kang, Eun Joo;
- ... Cho, Jinhyun;
- 외 13명
Citations
WEB OF SCIENCE
1- 제목
- A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).
- 저자
- Park, Sehhoon; Lee, Yun-Gyoo; Park, Ji Hyun; Lee, Gyeong-Won; Kang, Eun Joo; Choi, Yoon Ji; Shin, SeongHoon; Han, Ji-Youn; Lee, Suee; Kim, YuJung; Kim, Tae Min; Kim, Sang-We; Shim, Byoung Yong; Cho, Jinhyun; Kim, Hye Sook; Park, Sang Gon; Lee, Ki Hyeong; Kim, Ilhwan; Ahn, Myung-Ju
- 발행일
- 2020-05
- 유형
- Meeting Abstract
- 권
- 38
- 호
- 15